For a long time, Lupin was awaiting the approval of US Food and Drug Authority for its oral contraceptive pill known as Yasmin and it has finally got it. Lupin made the announcement and said that it will soon be launching the generic version of Lupin in the market.

Experts said that it was great to know that Yasmin will soon be available in the market. It has great potential to generate huge sales in the market. If to go as per the predictions of experts then it is said that the company will be able to get 10% of market shares in next year.

It shall be noted that the generic version of the drug known as the Drospirenone and Ethinyl Estradiol tablets will be sold in the American market. "Lupin will be marketing its Drospirenone and Ethinyl Estradiol tablets USP in a wallet pack of 28 tablets consisting of 21 yellow active tablets", said the company officials.

Each tablet will be containing 3 mg of Drospirenone and 0.03 mg of Ethinyl Estradiol. The recent drug approval shows the expanding oral contraceptive market in the US. Experts have valued the market to be around $5 billion and its value is increasing with every passing year.